Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Low-grade Glioma × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 110 Mesothelioma 61 Solid Tumor 42 Solid Tumors 32 Retinoblastoma 21 Solitary Fibrous Tumor, Pleural 19 Advanced Solid Tumors 14 Advanced Solid Tumor 14 Sarcoma 13 Lung Neoplasms 13 Small Cell Lung Carcinoma 10 Carcinoma, Non-Small-Cell Lung 10 Osteosarcoma 8 Neuroblastoma 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Solid Tumor, Adult 6 Ovarian Neoplasms 5 Neoplasms 5 Colorectal Neoplasms 5 Cholangiocarcinoma 5 Central Nervous System Neoplasms 5 Carcinoma, Renal Cell 5 Breast Neoplasms 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Melanoma 4 Medulloblastoma 4 Malignant Solid Tumor 4 Chondrosarcoma 4 Advanced Solid Tumour 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04775485 2025-04-10

FIREFLY-1

Day One Biopharmaceuticals, Inc.

Phase 2 Recruiting

141 enrolled 1 FDA

CNSOther solid neoplasm

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡